Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Circulating IL-10 is associated with reduced risk of prostate cancer in a prospective cohort of elderly men: the MrOS Study

Cancer Causes & Control(2022)10.1007/s10552-022-01639-xSource: DataRank Database

Circulating IL-10 is associated with reduced risk of prostate cancer in a prospective cohort of elderly men: the MrOS Study is a research paper published in Cancer Causes & Control (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

refsnp doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (23 grants)Impact (FWCI 1.09)OA: greenTopics (91)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Douglas C. Bauer ORCID,Jian‐Min Yuan ORCID,Jane A. Cauley ORCID,Claire E. Thomas ORCID

Live enrichment

PubMed:36239865 PMC:PMC11189667 OpenAlex:https://openalex.org/W4306247881

NIAMS NIH HHS

Grant: U01 AR066160

NIA NIH HHS

Grant: U01 AG042139

NCATS NIH HHS

Grant: UL1 TR000128

NIAMS NIH HHS

Grant: P60 AR054731

NIA NIH HHS

Grant: U01 AG027810

NIA NIH HHS

Grant: U01 AG042124

NIA NIH HHS

Grant: U01 AG042143

NIA NIH HHS

Grant: U01 AG042145

NIA NIH HHS

Grant: U01 AG042168

NCI NIH HHS

Grant: P30 CA047904

NCI NIH HHS

Grant: T32 CA186873

NIA NIH HHS

Grant: U01 AG042140

National Institutes of Health

Grant: 5U01AG042139-18

Osteoporotic Fractures in Men (Mr.OS)

National Institutes of Health

Grant: 4U01AG042140-17

Osteoporotic Fractures in Men_MrOS Renewal_Birmingham

National Institutes of Health

Grant: 3U01AG042145-18S1

Osteoporotic Fractures in Men (MrOS) - Minneapolis

National Institutes of Health

Grant: 5P60AR054731-03

PITT-MCRC for Rheumatic and Musculoskeletal Diseases

National Institutes of Health

Grant: 5U01AG027810-05

Osteporotic Fractures in Men (MrOS)- Admin Center

National Institutes of Health

Grant: 5U01AG042143-16

Osteoporotic Fractures in Men (Mr. Os) Palo Alto

National Institutes of Health

Grant: 2T32CA186873-11

Translational Research Training in Cancer Prevention and Control

National Institutes of Health

Grant: 4U01AG042124-17

Osteoporotic Fractures in Men (MrOS) - Portland

National Institutes of Health

Grant: 5U01AG042168-16

Osteoporatic Fractures in Men (MrOS)

National Institutes of Health

Grant: 5UL1TR000128-10

Oregon Clinical and Translational Research Institute

National Institutes of Health

Grant: 9U01AR066160-14A1

Osteoporotic Fractures in Men (MrOS) - San Francisco Coordinating Center

FWCI

1.09

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

greenLicense: Springer Nature TDM

repositoryhttps://escholarship.org/content/qt8w57c8sv/qt8w57c8sv.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10552-022-01639-x.pdf

publisherhttps://link.springer.com/article/10.1007/s10552-022-01639-x/fulltext.html

repositoryhttps://escholarship.org/uc/item/8w57c8sv

Fields of Study

Prostate Cancer Treatment and ResearchInflammatory Biomarkers in Disease PrognosisCancer, Lipids, and Metabolism0302 clinical medicine03 medical and health sciencesMaleHumansAgedInterleukin-10Risk FactorsProspective StudiesInflammationBiomarkersCytokinesInterleukin-6Prostatic Neoplasms

MeSH Terms

AgedHumansInflammationMaleProspective StudiesProstatic NeoplasmsRisk FactorsBiomarkersInterleukin-6CytokinesInterleukin-10

Keywords

MedicineProstate cancerHazard ratioProspective cohort studyInternal medicineCancerOncologyProportional hazards modelCohortBiomarkerCohort studyConfidence intervalCytokinesInflammationMolecular epidemiologyIL-10Prevention (rcdc)MaleAging1117 Public Health and Health Services (for)EpidemiologyProstate Cancer (rcdc)Interleukin-10 (mesh)Aging (rcdc)Risk Factors2.1 Biological and endogenous factorsProspective Studies32 Biomedical and Clinical Sciences (for-2020)Male (mesh)Cancer (rcdc)Humans (mesh)1112 Oncology and Carcinogenesis (for)Interleukin-10Biomarkers (mesh)4.2 Evaluation of markers and technologies (hrcs-rac)Public Health and Health Services4.2 Evaluation of markers and technologiesInterleukin-6 (mesh)Prostatic Neoplasms (mesh)Urologic DiseasesInflammation (mesh)Clinical SciencesOncology and Carcinogenesis610Epidemiology (science-metrix)Risk Factors (mesh)3211 Oncology and carcinogenesis (for-2020)HumansProspective Studies (mesh)3202 Clinical Sciences (for-2020)AgedBiomedical and Clinical SciencesAged (mesh)Interleukin-6Prevention4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac)Prostatic Neoplasms2.1 Biological and endogenous factors (hrcs-rac)Cancer (hrcs-hc)4.1 Discovery and preclinical testing of markers and technologiesCytokines (mesh)Urologic Diseases (rcdc)4202 Epidemiology (for-2020)Biomarkers

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Circulating IL-10 is associated with reduced risk of prostate cancer in a prospective cohort of elderly men: the MrOS Study

FAIR Checklist

Authors (4)

Funding (23 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)